ArticleAmerican journal of cancer research2019

Oxymatrine enhanced anti-tumor effects of Bevacizumab against triple-negative breast cancer via abating Wnt/β-Catenin signaling pathway.

Wei Xie et al.PubMed ↗Full text ↗

No numbers read from the abstract.